Drug and Alcohol Dependence
Volume 111, Issue 1 , Pages 74-81 , 1 September 2010

Prevalence and predictors of transitions to and away from syringe exchange use over time in 3 US cities with varied syringe dispensing policies

  • Traci C. Green

      Affiliations

    • School of Public Health, Yale University, New Haven, CT 06520, USA
    • Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT 06520, USA
    • Corresponding Author InformationCorresponding author at: Brown Medical School, 111 Plain St. Building, Rm 111, Providence, RI 02903, USA. Tel.: +1 401 444 3845; fax: +1 401 444 5040.
    • ,
  • Ricky N. Bluthenthal

      Affiliations

    • RAND Corporation and Department of Sociology, California State University, Dominguez Hills, Carson, CA 90747, USA
    • ,
  • Merrill Singer

      Affiliations

    • Department of Anthropology and the Center for Health, Intervention and Prevention, University of Connecticut, Storrs, CT 06269, USA
    • ,
  • Leo Beletsky

      Affiliations

    • Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT 06520, USA
    • ,
  • Lauretta E. Grau

      Affiliations

    • School of Public Health, Yale University, New Haven, CT 06520, USA
    • Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT 06520, USA
    • ,
  • Patricia Marshall

      Affiliations

    • Department of Bioethics, Case Western Reserve University, Cleveland, OH 44106, USA
    • ,
  • Robert Heimer

      Affiliations

    • School of Public Health, Yale University, New Haven, CT 06520, USA
    • Center for Interdisciplinary Research on AIDS, Yale University, New Haven, CT 06520, USA

Received 5 October 2009 ,Revised 23 March 2010 ,Accepted 26 March 2010.

References 

  1. Bastos FI, Strathdee SA. Evaluating effectiveness of syringe exchange programmes: current issues and future prospects. Social Science & Medicine. 2000;51(12):1771–1782
  2. Beletsky, L., Heimer, R., Grau, L.E., 2009. Police-Public Health Collaboration in HIV Prevention: A Needs-Assessment Survey. AIDS Science Day, Yale Center for Interdisciplinary Research on AIDS, New Haven, CT.
  3. Beletsky L, Macalino GE, Burris S. Attitudes of police officers towards syringe access, occupational needle-sticks, and drug use: a qualitative study of One City Police Department in the United States. International Journal of Drug Policy. 2005;16:267–274
  4. Beyer L, Crofts N, Reid G. Drug offending and criminal justice responses: practitioners’ perspectives. The International Journal on Drug Policy. 2002;13:199–207
  5. Bluthenthal RN, Anderson R, Flynn NM, Kral AH. Higher syringe coverage is associated with lower odds of HIV risk and does not increase unsafe syringe disposal among syringe exchange program clients. Drug and Alcohol Dependence. 2007;89:214–222
  6. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study. AIDS (London, England). 2000;14:605–611
  7. Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco. Medical Anthropology. 1997;18:61–83
  8. Bluthenthal RN, Malik MR, Grau LE, Singer M, Marshall P, Heimer R. Sterile syringe access conditions and variations in HIV risk among drug injectors in three cities. Addiction (Abingdon, England). 2004;99:1136–1146
  9. Bluthenthal RN, Ridgeway G, Schell T, Anderson R, Flynn NM, Kral AH. Examination of the association between syringe exchange program (SEP) dispensation policy and SEP client-level syringe coverage among injection drug users. Addiction (Abingdon, England). 2007;102:638–646
  10. Bluthenthal RN, Watters JK. Multimethod research: from targeted sampling to HIV risk behaviors. In:  Lambert EY,  Ashery RS,  Needle RH editor. Qualitative Methods in the Prevention of Drug Abuse. Rockville, MD: National Institute on Drug Abuse; 1995;p. 212–230
  11. Bourgois P. The moral economies of homeless heroin addicts: confronting ethnography, HIV risk, and everyday violence in San Francisco shooting encampments. Substance Use & Misuse. 1998;33:2323–2351
  12. Bryant J, Hopwood M. Secondary exchange of sterile injecting equipment in a high distribution environment: a mixed method analysis in south east Sydney, Australia. International Journal of Drug Policy. 2009;20:324–328
  13. Centers for Disease Control and Prevention, 2009. HIV/AIDS Surveillance Report, 2007, vol. 19. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, Atlanta.
  14. Chaisson RE, Moss AR, Onishi R, Osmond D, Carlson JR. Human immunodeficiency virus infection in heterosexual intravenous drug users in San Francisco. American Journal of Public Health. 1987;77:169–172
  15. Clatts MC, Sotheran JL, Luciano PA, Gallo TM, Kochems LM. The impact of drug paraphernalia laws on HIV risk among persons who inject illegal drugs: implications for public policy. In:  Fish JM editors. How to Legalize Drugs. Northvale, NJ: Jason Aronson; 1998;p. 90–101
  16. Davis CS, Burris S, Kraut-Becher J, Lynch KG, Metzger D. Effects of an intensive street-level police intervention on syringe exchange program use in Philadelphia, PA. American Journal of Public Health. 2005;95:233–236
  17. De P, Cox J, Boivin J-F, Platt R, Jolly A. Social network-related risk factors for bloodborne virus infections among injection drug users receiving syringes through secondary exchange. Journal of Urban Health. 2008;85:77–89
  18. DeBeck K, Wood E, Zhang R, Tyndall M, Montaner J, Kerr T. Police and public health partnerships: evidence from the evaluation of Vancouver's supervised injection facility. Substance Abuse Treatment, Prevention, and Policy. 2008;3:11
  19. Des Jarlais DC, Marmor M, Paone D, Titus S, Shi Q, Perlis T, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet. 1996;348:987–991
  20. Grau LE, Bluthenthal RN, Marshall P, Singer M, Heimer R. Psychosocial and behavioral differences among drug injectors who use and do not use syringe exchange programs. AIDS and Behavior. 2005;9:495–504
  21. Green, T.C., Smith-Rohrberg, D., Allen, N., Heimer, R., Grau, L.E., 2006. Exploring the diffusion of benefit of syringe exchange programs in a cohort of injecting drug users: changes in injecting behaviors and injecting-related morbidity. Summer Institute in Longitudinal Research, Center for Advancing Longitudinal Drug Abuse Research, UCLA, Los Angeles, CA.
  22. Grund JP, Stern LS, Kaplan CD, Adriaans NF, Drucker E. Drug use contexts and HIV-consequences: the effect of drug policy on patterns of everyday drug use in Rotterdam and the Bronx. British Journal of Addiction. 1992;87:381–392
  23. Hankins C, Alary M, Parent R, Blanchette C, Claessens C. Continuing HIV transmission among injection drug users in Eastern Central Canada: the SurvUDI Study, 1995 to 2000. Journal of Acquired Immune Deficiency Syndromes. 2002;30(5):514–521
  24. Heimer R. Community coverage and HIV prevention: assessing metrics for estimating HIV incidence through syringe exchange. The International Journal on Drug Policy. 2008;19(Suppl. 1):S65–S73
  25. Heimer R, Bluthenthal RN, Singer M, Khoshnood K. Structural impediments to operational syringe-exchange programs. AIDS & Public Policy Journal. 1996;11:169–184
  26. Heimer R, Clair S, Grau LE, Bluthenthal RN, Marshall PA, Singer M. Hepatitis-associated knowledge is low and risks are high among HIV-aware injection drug users in three US cities. Addiction (Abingdon, England). 2002;97:1277–1287
  27. Heimer R, Clair S, Teng W, Grau LE, Khoshnood K, Singer M. Effects of increasing syringe availability on syringe-exchange use and HIV risk: Connecticut, 1990–2001. Journal of Urban Health. 2002;79:556–570
  28. Heimer R, Khoshnood K, Bigg D, Guydish J, Junge J. Syringe use and re-use: effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology. 1998;18(Suppl. 1):S37–44
  29. Heinzerling KG, Kral AH, Flynn NM, Anderson RL, Scott A, Gilbert ML, et al. Human immunodeficiency virus and hepatitis C virus testing services at syringe exchange programs: availability and outcomes. Journal of Substance Abuse Treatment. 2007;32:423–429
  30. Huo D, Bailey SL, Hershow RC, Ouellet L. Drug use and HIV risk practices of secondary and primary needle exchange users. AIDS Education and Prevention: Official Publication of the International Society for AIDS Education. 2005;17:170–184
  31. Koester SK. Copping, running, and paraphernalia laws: contextual and needle risk behavior among injection drug users in denver. Human Organization. 1994;53:287–295
  32. Kral AH, Anderson R, Flynn NM, Bluthenthal RN. Injection risk behaviors among clients of syringe exchange programs with different syringe dispensation policies. Journal of Acquired Immune Deficiency Syndromes. 2004;37(1999):1307–1312
  33. Lanza ST, Collins LM. A new SAS procedure for latent transition analysis: transitions in dating and sexual risk behavior. Developmental Psychology. 2008;44:446–456
  34. Lorvick J, Bluthenthal RN, Scott A, Gilbert ML, Riehman KS, Anderson RL, et al. Secondary syringe exchange among users of 23 California syringe exchange programs. Substance Use & Misuse. 2006;41:865–882
  35. Marmor M, Des Jarlais DC, Cohen H, Friedman SR, Beatrice ST, Dubin N, et al Risk factors for infection with human immunodeficiency virus among intravenous drug abusers in New York City. AIDS (London, England). 1987;1:39–44
  36. Martinez AN, Bluthenthal RN, Lorvick J, Anderson R, Flynn N, Kral AH. The impact of legalizing syringe exchange programs on arrests among injection drug users in California. Journal of Urban Health. 2007;84:423–435
  37. Muthen LK, Muthen B. Mplus User's Guide. Los Angeles: Muthen & Muthen; 2007;
  38. Schoenbaum EE, Hartel D, Selwyn PA, Klein RS, Davenny K, Rogers M, et al. Risk factors for human immunodeficiency virus infection in intravenous drug users. The New England Journal of Medicine. 1989;321:874–879
  39. Sears C, Guydish JR, Weltzien EK, Lum PJ. Investigation of a secondary syringe exchange program for homeless young adult injection drug users in San Francisco, California, U. S. A. JAIDS Journal of Acquired Immune Deficiency Syndromes. 2001;27:193–201
  40. Shutz C, Rapiti E, Vlahov D, Anthony J. Suspected determinants of enrollment into detoxification and methadone treatment among injecting drug users. Drug and Alcohol Dependence. 1994;36:129–138
  41. Singer M, Irizarry R, Schensul JJ. Needle access as an AIDS prevention strategy for IV drug users: a research perspective. Human Organization. 1991;50:142–153
  42. Singer M, Weeks MR. Hartford Targeted Sampling Plan. Hartford, CT: Community Alliance for AIDS Programs; 1992;
  43. Strathdee SA, Celentano DD, Shah N, Lyles C, Stambolis VA, Macalino G, et al. Needle-exchange attendance and health care utilization promote entry into detoxification. Journal of Urban Health. 1999;76:448–460
  44. Valente TW, Foreman RK, Junge B, Vlahov D. Satellite exchange in the Baltimore Needle Exchange Program. Public Health Reports. 1998;113(Suppl. 1):90–96
  45. Vlahov D, Junge B, Brookmeyer R, Cohn S, Riley E, Armenian H, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology. 1997;16(5):400–406
  46. Weatherburn D, Lind B. Street-level drug law enforcement and entry into methadone maintenance treatment. Addiction (Abingdon, England). 2001;96:577–587

PII: S0376-8716(10)00162-6

doi: 10.1016/j.drugalcdep.2010.03.022

Drug and Alcohol Dependence
Volume 111, Issue 1 , Pages 74-81 , 1 September 2010

Article Tools

* Image Usage & Resolution